Action MetaStat (CE) - MTST

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

0,0001

Prix Achat

0,00

Prix Vente

0,00

Volume échangé

0,00 Fourchette du Jour 0,00

0,0001 Plage de 52 semaines 0,003

Clôture Veille

0,0001

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

MetaStat CEO Oscar L. Bronsther, M.D. to Participate in Moffitt Cancer Center’s 9th Annual Bus. of Biotech Conference in Ta...

Bronsther to Participate in Panel on Raising Funds in Biotech Oscar L. Bronsther, M.D., CEO of MetaStat, Inc. (OTCQB:MTST), a molecular...

MetaStat Discussed in Medscape and Other News Outlets

Interviews Spotlight Importance of Company’s Diagnostic Tests for Predicting Metastasis in Patients with Breast Cancer MetaStat, Inc...

MetaStat Appoints Martin J. Driscoll to Board of Directors

Thirty Years of Biopharmaceutical Industry Experience Includes Leadership, Development and Commercialization MetaStat, Inc. (OTCQB:MTST...

MetaStat Announces Closing of Series B Private Placement

-- Company Raises Total Gross Proceeds of $3.4 Million -- MetaStat, Inc. (OTCQB:MTST), a molecular diagnostic company focused on developing...

MetaStat Enters into Agreement to Access Tumor Samples and Clinical Data from Kaiser Foundation Hospitals

Research Represents Next Step Forward in Path Toward Commercialization of Company’s Diagnostic Tests MetaStat, Inc. (OTCQB: MTST), a...

MetaStat Closes First Round of a $3.5 Million Private Placement

MetaStat, Inc. (OTCQB:MTST), a molecular diagnostic company focused on developing and commercializing epigenetic-based diagnostic tests for...

MetaStat to Present at Biotech Showcase 2015 in San Francisco

CEO Oscar L. Bronsther to Present on Tuesday, January 13 at 10:30 AM PT MetaStat, Inc. (OTCQB:MTST), a molecular diagnostic company focused...

MetaStat Completes Divestiture of Its Therapeutic Assets

Becomes Pure-Play Molecular Diagnostics Company, Focused Exclusively on Developing and Commercializing Epigenetic-based Diagnostic Tests to...

MetaStat Spotlighted in Three Publications

Company’s Diagnostic Tests for Early Detection of Systemic Metastasis Spotlighted in Boston Magazine, Medical Device Daily and MedCity News...

MetaStat Appoints Richard J. Berman and H. Philip Goodeve to Board of Directors

Decades of Experience Add Strength to Board MetaStat, Inc. (OTCQB:MTST), a molecular diagnostic company focused on understanding and...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0.0001	0.0001	0.0001	0	0	CS
26	0	0	0.0001	0.0001	0.0001	1146	0.0001	CS
52	0	0	0.0001	0.003	0.0001	11469	0.00110028	CS
156	9.9E-5	9900	1.0E-6	0.003	1.0E-6	7864	0.00109805	CS
260	-0.0034	-97.1428571429	0.0035	0.075	1.0E-6	21321	0.00816991	CS

MTST - Frequently Asked Questions (FAQ)

What is the current MetaStat (CE) share price?

The current share price of MetaStat (CE) is US$ 0,0001

What is the 1 year trading range for MetaStat (CE) share price?

MetaStat (CE) has traded in the range of US$ 0,0001 to US$ 0,003 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
STTOSITO Mobile Ltd (CE)	US$ 0,05 (24 900,00%)	278
VNTNVenturenet Capital Group Inc (CE)	US$ 0,0002 (19 900,00%)	8,61M
GCFBGranite City Food and Brewery Ltd (CE)	US$ 0,0001 (9 900,00%)	12,31k
BIIOBionovate Technologies Corporation (CE)	US$ 0,0001 (9 900,00%)	152
CBUIFCommodore International (CE)	US$ 0,0001 (9 900,00%)	1,9k
KREDKonaRed Corporation New (CE)	US$ 0,000001 (-100,00%)	220,8k
TMPOQTempo Automation Holdings Inc (CE)	US$ 0,000001 (-100,00%)	714
TCNTToucan Interactive Corp (CE)	US$ 0,0003 (-99,98%)	1,7k
ZUUSZEUUS Inc (CE)	US$ 0,0025 (-99,88%)	235
MHHCMHHC Enterprises Inc (CE)	US$ 0,000001 (-99,50%)	1,21M
AFFUAffluence Corp (PK)	US$ 0,0004 (0,00%)	463,15M
QEDNQED Connect Inc (PK)	US$ 0,0002 (-33,33%)	181,97M
CGACCode Green Apparel Corp (PK)	US$ 0,0003 (50,00%)	172,29M
ICTYEyecity Com Inc (PK)	US$ 0,0005 (25,00%)	134,27M
HMBLHUMBL Inc (PK)	US$ 0,0003 (20,00%)	125,6M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

MetaStat Inc (CE) (MTST)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

MTST Dernières nouvelles

MetaStat CEO Oscar L. Bronsther, M.D. to Participate in Moffitt Cancer Center’s 9th Annual Bus. of Biotech Conference in Ta...

MetaStat Discussed in Medscape and Other News Outlets

MetaStat Appoints Martin J. Driscoll to Board of Directors

MetaStat Announces Closing of Series B Private Placement

MetaStat Enters into Agreement to Access Tumor Samples and Clinical Data from Kaiser Foundation Hospitals

MetaStat Closes First Round of a $3.5 Million Private Placement

MetaStat to Present at Biotech Showcase 2015 in San Francisco

MetaStat Completes Divestiture of Its Therapeutic Assets

MetaStat Spotlighted in Three Publications

MetaStat Appoints Richard J. Berman and H. Philip Goodeve to Board of Directors

MTST - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

MetaStat Inc (CE) (MTST) Cours

MetaStat Inc (CE) (MTST)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

MTST Dernières nouvelles

MetaStat CEO Oscar L. Bronsther, M.D. to Participate in Moffitt Cancer Center’s 9th Annual Bus. of Biotech Conference in Ta...

MetaStat Discussed in Medscape and Other News Outlets

MetaStat Appoints Martin J. Driscoll to Board of Directors

MetaStat Announces Closing of Series B Private Placement

MetaStat Enters into Agreement to Access Tumor Samples and Clinical Data from Kaiser Foundation Hospitals

MetaStat Closes First Round of a $3.5 Million Private Placement

MetaStat to Present at Biotech Showcase 2015 in San Francisco

MetaStat Completes Divestiture of Its Therapeutic Assets

MetaStat Spotlighted in Three Publications

MetaStat Appoints Richard J. Berman and H. Philip Goodeve to Board of Directors

MTST - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités